Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Autologous Autovaccine in Patients With Allergy on House-dust-mite

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* informed consent~* age 18-35 years~* known allergy on house-dust mite~* GINA 0-1~Exclusion Criteria:~* anamnestic incompatibility to parts of autovaccine~* asthma \> GINA I°~* chronic disease conditions or infections~* pregnancy~* inhalative or systemic steroid use~* any immunosuppressive therapy~* intake of any other probiotic medication (e.g. E.coli nissle 1917)~* participation in any other study at the same time~* substance abuse~* Incapability of understanding the study's purpose and performance~* smoker

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): house dust mite allergics will undergo autovaccine immunization

Based on this trial design, predict the completion outcome and termination type (if applicable).